Introducing Drugonfly; A Novel Computer-Aided Drug Repurposing Pipeline Based on Genomic, Structural and Physicochemical Profiles

Conference paper
Part of the Lecture Notes in Computer Science book series (LNCS, volume 12462)


Herein, we are proposing a novel and radical pipeline that will facilitate the repurposing of approved drugs in an unprecedented way that will eventually yield invaluable insights and results that will aid the pharma-medical domain to tackle many more pathologies using weaponry that has already been approved, is safe for the public, is very rapid relatively to conventional drug design and requires no further significant investment to be made. The ultimate goal is to develop a novel clinical concept and establish a computer-aided pipeline that will facilitate and rationalize the repurposing of approved drugs, orphan drugs and generics. The end result of the described pipeline is a competitive and reliable software that will be made available for the scientific community.


Drug design Drug repurposing Bioinformatics Metagenomics Data mining Data analytics 


  1. 1.
    Dalkas, G.A., Vlachakis, D., Tsagkrasoulis, D., Kastania, A., Kossida, S.: State-of-the-art technology in modern computer-aided drug design. Briefings Bioinf. 14, 745–752 (2013). Scholar
  2. 2.
    Tsagrasoulis, D., Vlachakis, D., Megalooikonomou, V., Kossida, S: Introducing Drugster: a comprehensive and fully integrated drug design, lead and structure optimization toolkit. Bioinformatics 29, 126–128 (2013e).
  3. 3.
    Antoniou, N., et al.: A motif within the armadillo repeat of Parkinson’s-linked LRRK2 interacts with FADD to hijack the extrinsic death pathway. Sci. Rep. 8 (2018).
  4. 4.
    Amidi, A., Amidi, S., Vlachakis, D., Megalooikonomou, V., Paragios, N., Zacharaki, E.I.: EnzyNet: enzyme classification using 3D convolutional neural networks on spatial representation. PeerJ (2018).
  5. 5.
    Kontopoulos, D.G., Vlachakis, D., Tsiliki, G., Kossida, S.: Structuprint: a scalable and extensible tool for two-dimensional representation of protein surfaces. BMC Struct. Biol. 16 (2016b).
  6. 6.
    Papageorgiou, L., Cuong, N.T., Vlachakis, D.: Antibodies as stratagems against cancer. Mol. BioSyst. 12(7), 2047–2055 (2016). Scholar
  7. 7.
    Papageorgiou, L., Vlachakis, D.: Antisoma application: a fully integrated V-like antibodies platform AIMS. Med. Sci. 4, 382–394 (2017). Scholar
  8. 8.
    Tsiliki, G., Vlachakis, D., Kossida, S.: On integrating multi-experiment microarray data. Philos. Trans. R. Soc. A Math. Phys. Eng. Sci., 372 (2014).
  9. 9.
    Vlachakis, D.: Theoretical study of the Usutu virus helicase 3D structure, by means of computer- aided homology modelling. Theor. Biol. Med. Model. 6, 9 (2009).
  10. 10.
    Vlachakis, D., Bencurova, E., Papangelopoulos, N., Kossida, S.: Current state-of-the-art molecular dynamics methods and applications. In: Advances in Protein Chemistry and Structural Biology, vol. 94, pp. 269–313. Academic Press (2014b).
  11. 11.
    Vlachakis, D., Fakourelis, P., Megalooikonomou,V., Makris, C., Kossida, S.: DrugOn: a fully integrated pharmacophore modeling and structure optimization toolkit. PeerJ (2015).
  12. 12.
    Vlachakis, D., Koumandou, V.L., Kossida, S.: A holistic evolutionary and structural study of flaviviridae provides insights into the function and inhibition of HCV helicase. PeerJ (2013c).

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Genetics and Computational Biology Group, Laboratory of Genetics, Department of Biotechnology, School of Applied Biology and BiotechnologyAgricultural University of AthensAthensGreece
  2. 2.Laboratory of Molecular Endocrinology, Division of Endocrinology and Metabolism, Center of ClinicalExperimental Surgery and Translational Research, Biomedical Research Foundation, Academy of AthensAthensGreece
  3. 3.University Research, Institute of Maternal and Child Health and Precision MedicineMedical School, National and Kapodistrian University of AthensAthensGreece

Personalised recommendations